Anthony Linton

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

Nico van Zandwijk, Nick Pavlakis, Steven Kao et al. · The Lancet Oncology · 2017 · 709 citations

Medicine, Oncology, Pharmacology +15

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Steven Kao, Yuen Yee Cheng, Marissa Williams et al. · Journal of Thoracic Oncology · 2017 · 146 citations

Medicine, Cancer Biology, Oncology +16

miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma

Marissa Williams, Michaela B. Kirschner, Yuen Yee Cheng et al. · Oncotarget · 2015 · 85 citations · Full text

Medicine, Cancer Biology, Oncology +13

Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales

Anthony Linton, Nick Pavlakis, Rachel O’Connell et al. · British Journal of Cancer · 2014 · 82 citations · Full text

Medicine, Oncology, Pathology +17

MiR‐Score: A novel 6‐microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma

Michaela B. Kirschner, Yuen Yee Cheng, Nicola J. Armstrong et al. · Molecular Oncology · 2014 · 77 citations · Full text

Medicine, Bioinformatics, Oncology +13